Maharashtra FDA Targets Surrogate Ads

The Maharashtra Food and Drug Administration (FDA) has once again taken on the issue of surrogate advertising, a tactic often used by companies to promote products that are banned or restricted. This practice involves using indirect means to advertise products, such as promoting a related item or service that is not banned. The FDA's move is aimed at protecting consumers from the harmful effects of such products. In the past, the Maharashtra FDA has taken similar action against gutkha manufacturers who used surrogate advertising to promote their products.